^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
tepoditamab (MCLA-117)
i
Other names: MCLA-117
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Gustave Roussy, Merus
Drug class:
CD3 agonist, CLL-1 inhibitor
Related drugs:
